We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

5 hedge funds and large institutions have $86K invested in NeuroMetrix, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

8.59% less ownership

Funds ownership: 9.7% → 1.11% (-8.6%)

20% less capital invested

Capital invested by funds: $108K → $86K (-$22K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WS
Wedbush Securities
California
+$44.4K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$34.4K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$8.63K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$93K
2
RIA
Realta Investment Advisors
Delaware
-$13K

NURO Hedge Fund Activity: Q2 2020 in Review

5 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2020, worth a combined $86K — down 20% from $108K a quarter earlier.

Fund positioning in NURO was balanced in Q2 2020: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Wedbush Securities, opening a new position worth an estimated $44.4K. The largest seller was Sabby Management, exiting entirely with an estimated $93K sold.

  • 5 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $86K of NeuroMetrix, Inc. Common Stock stock for Q2 2020, down 20% quarter-over-quarter.
  • 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2020 and 3 closed out, a net change of 0 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2020 was Wedbush Securities, an estimated $44.4K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2020 was Sabby Management, an estimated $93K sold.

Based on aggregated 13F filings for Q2 2020.